Literature DB >> 3613914

The effects of disease verification and referral on the relationship between symptoms and diseases.

J A Knottnerus.   

Abstract

Reference symptoms of individual diseases, which are usually gleaned from hospital-based observations, may not be pertinent to primary health care. Observed relationships between symptoms and diseases can be biased by consultation, disease verification, and referral patterns. These biases are shown to affect sensitivity, specificity, predictive values, the likelihood ratio, and the odds ratio. On the assumption that consultation and disease verification rates are positively influenced by symptoms, but not directly by the yet unknown disease status of the patient, the general practitioner will observe a higher sensitivity and a lower specificity than in an unselected population. A positive correlation between symptom and disease will decrease the likelihood ratio, while the predictive values and the odds ratio are not changed after consultation. Referral is influenced by both symptom status and disease verification status. In general, the disease verification and referral patterns of general practitioners have not been quantified. While the influence of referral cannot easily be corrected for, the likely magnitude and direction of selection bias can be evaluated using simple formulas. A possible way to make unbiased estimations from populations preselected by referral is to compute the predictive values and the odds ratio from the category of patients referred without pre-existing knowledge of the disease status.

Entities:  

Mesh:

Year:  1987        PMID: 3613914     DOI: 10.1177/0272989X8700700304

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  8 in total

Review 1.  Diagnosis and general practice.

Authors:  N Summerton
Journal:  Br J Gen Pract       Date:  2000-12       Impact factor: 5.386

2.  How well do general practitioners manage dyspepsia?

Authors:  D K Warndorff; J A Knottnerus; L G Huijnen; R Starmans
Journal:  J R Coll Gen Pract       Date:  1989-12

3.  Diagnostic value of history and physical examination in patients suspected of lumbosacral nerve root compression.

Authors:  P C A J Vroomen; M C T F M de Krom; J T Wilmink; A D M Kester; J A Knottnerus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

Review 4.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; Jeroen G Lijmer; David Moher; Drummond Rennie; Henrica C W de Vet
Journal:  BMJ       Date:  2003-01-04

Review 5.  Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis.

Authors:  Marcus C de Jong; Tessa S S Genders; Robert-Jan van Geuns; Adriaan Moelker; M G Myriam Hunink
Journal:  Eur Radiol       Date:  2012-04-19       Impact factor: 5.315

Review 6.  Clinical implications of referral bias in the diagnostic performance of exercise testing for coronary artery disease.

Authors:  Joseph A Ladapo; Saul Blecker; Michael R Elashoff; Jerome J Federspiel; Dorice L Vieira; Gaurav Sharma; Mark Monane; Steven Rosenberg; Charles E Phelps; Pamela S Douglas
Journal:  J Am Heart Assoc       Date:  2013-12-13       Impact factor: 5.501

7.  Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma.

Authors:  Antonius Schneider; Gudrun Wagenpfeil; Rudolf A Jörres; Stefan Wagenpfeil
Journal:  BMJ Open       Date:  2015-11-24       Impact factor: 2.692

8.  Seq-SymRF: a random forest model predicts potential miRNA-disease associations based on information of sequences and clinical symptoms.

Authors:  Jinlong Li; Xingyu Chen; Qixing Huang; Yang Wang; Yun Xie; Zong Dai; Xiaoyong Zou; Zhanchao Li
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.